Stock Track | Lightspeed Stock Surges on Strong Q2 Results and Raised Guidance

Stock Track11-07

Lightspeed Commerce Inc. (LSPD) shares soared 5.39% in pre-market trading on November 7, 2024, after the company reported impressive financial results for the second quarter of fiscal 2025, beating analyst estimates on both the top and bottom lines. The company also raised its Adjusted EBITDA guidance for the full fiscal year, fueling investor optimism.

For the quarter ended September 30, 2024, Lightspeed reported total revenue of $277.2 million, up 20% year-over-year and surpassing the consensus estimate of $274.08 million. The growth was driven by a 33% increase in transaction-based revenue to $183.8 million and a 6% rise in subscription revenue to $85.5 million.

Adjusted EPS came in at $0.13, beating the consensus estimate of $0.11. Adjusted EBITDA stood at $14.0 million, exceeding the company's outlook of $12 million. Lightspeed also reported positive Adjusted Free Cash Flow of $1.6 million, reflecting the company's initiatives to expand payments adoption and control costs.

Encouraged by the strong performance, Lightspeed raised its Adjusted EBITDA outlook for fiscal 2025 to a minimum of $50 million from the previous guidance of at least $45 million. The company expects revenue growth of at least 20% for the full year.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment